SCHEMBL605156

SCHEMBL605156

CN(C)C1CN(c2cc(-c3ccccc3)nc(N)n2)C1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.62
HRH4 Q9H3N8 3/20 0.61
HTR3A P46098 3/20 0.61
USP2 O75604 1/20 0.60
LMNA P02545 1/20 0.60
TSHR P16473 1/20 0.60
HTT P42858 1/20 0.60
HSD17B10 Q99714 1/20 0.60
SCN2A Q99250 1/20 0.51
ADORA2A P29274 1/20 0.50
ADORA1 P30542 1/20 0.50
HTR1D P28221 2/20 0.46
HTR6 P50406 2/20 0.46
TMEM97 Q5BJF2 2/20 0.46
HTR1A P08908 1/20 0.46
DRD2 P14416 1/20 0.46
HTR1B P28222 1/20 0.46
MAPK8 P45983 1/20 0.46
SLC6A3 Q01959 1/20 0.46
BTK Q06187 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL602600 0.89 HTR3A (0.58) HRH3HRH4HTR3AUSP2LMNA
SCHEMBL6510068 0.86 HRH4 (0.55) HRH3HRH4HTR3AUSP2LMNA
Hydrochloric Acid SCHEMBL6508476 0.82 LMNA (0.65) HRH3HRH4HTR3AUSP2LMNA
SCHEMBL605428 0.81 HRH4 (0.61) HRH3HRH4HTR3AUSP2LMNA
Hydrochloric Acid SCHEMBL6512235 0.80 HRH3 (0.63) HRH3HRH4HTR3AUSP2LMNA
SCHEMBL6023054 0.80 HTR3A (0.54) HRH4HTR3AUSP2LMNATSHR
SCHEMBL10567412 0.79 HRH4 (0.85) HRH3HRH4HTR3AUSP2LMNA
SCHEMBL2167865 0.76 HRH4 (1.00) HRH3HRH4HTR3AUSP2LMNA
SCHEMBL602911 0.76 HRH4 (0.65) HRH3HRH4HTR3AUSP2LMNA
SCHEMBL6512558 0.75 LMNA (0.56) HRH3HRH4HTR3AUSP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005054239-A1 2-AMINOPYRIMIDINE DERIVATIVES BAYER HEALTHCARE AG (DE) 2005-06-16 WO claimed
US-10195195-B2 Selective histamine H4 receptor antagonists for the treatment of vestibular disorders INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2019-02-05 US disclosed
EP-3378476-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2018-09-26 EP disclosed
US-9688989-B2 H4 receptor inhibitors for treating tinnitus SENSORION (FR) 2017-06-27 US disclosed
US-20170056397-A1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-03-02 US disclosed
EP-3130376-A1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-02-15 EP disclosed
US-9526725-B2 Selective histamine H4 receptor antagonists for the treatment of vestibular disorders INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2016-12-27 US disclosed
EP-2382013-B1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS. INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE (FR) 2016-07-13 EP disclosed
US-20150176010-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2015-06-25 US disclosed
EP-2858647-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2015-04-15 EP disclosed
WO-2013182711-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2013-12-12 WO disclosed
US-20120039913-A1 Selective Histamine H4 Receptor Antagonists for the Treatment of Vestibular Disorders INSERM (institut National de la Sante de la Recher Medicale) (FR) 2012-02-16 US disclosed
EP-2382013-A1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS. INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2011-11-02 EP disclosed
WO-2010072829-A1 SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS. INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2010-07-01 WO disclosed
WO-2005054239-A1 2-AMINOPYRIMIDINE DERIVATIVES BAYER HEALTHCARE AG (DE) 2005-06-16 WO disclosed